NICE Diagnostic Guidance 12 (DG12); Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath. A short, objective comparison of these two devices has been created by Wessex AHSN, Here you can review a comparison between the two products.
Your Results
Search our archive for materials older than three years. PCRS takes no responsibility for the content of archived material.
287 resultsMaking a case for change In order to justify any investment on new services or equipment, it is important to make a case for change (business case), describe the intended impacts and outcomes of your project, and outline the costs and project plan to deliver it.
Health Education England elearning for healthcare, in partnership with NHS England and NHS Improvement, Accelerated Access Collaborative, WAHSN, AHSN Network, and the Office for Life Sciences, developed two elearning modules focused on FeNO in Asthma. These elearning modules are designed to enhance awareness of FeNO testing to support increasing the test’s uptake whilst also ensuring health care professionals are provided with the knowledge and skills required for the optimal use of this simple and safe test in the diagnosis and management of asthma.
NICE guidance is integral to the clinical care that we offer as Health Care Professionals (HCPs). It is important to consider the evidence bases for all pathways, tests and procedures that we undertake.
Quality Improvement (QI) helps us identify what works well and where we can make changes. In primary care, we don't have time or resources to spend on things that don't work, don't serve our patients, and that could be done more efficiently or effectively. QI is a commitment to continuously improving the quality of healthcare, focusing on the preferences and needs of the people who use services. (Royal College of General Practitioners 2017)
accuRx has created a FeNO template to send to patients prior to their appointment via text message. For information on what's included and how to find the template, have a look at the guidance document below.
This may include an understanding of the benefits of having a FeNO test, including:
Language can play a big barrier in healthcare delivery – for example, by preventing people accessing healthcare in an effectively and timely way, preventing people understand what they need to do to support their own self-management, or by preventing people from understanding their treatment and medication, all resulting in suboptimal care. Use the map below to gain insight into the languages spoken in your local area.
These templates are only available to EMIS and TPP users – they are not available to MicroTest and Vision users. See the FeNO toolkit for Excel based alternatives. This guide describes: Purpose of the templates Supporting Data Protection Impact Assessment (DPIA) Cost (free of charge) Contents of templates How to download the templates Searches The data submission process How to access support Further FeNO resources 1.